Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Citrine Global Corporation (PK) | CTGL | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.015 | 0.015 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.005 - 0.0419 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.015 | USD |
Citrine Global Corporation (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 14.48M | 965.48M | 313.13M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Citrine Global (PK) News
Date | Time | Source | News Article |
---|---|---|---|
2/23/2024 | 14:15 | Edgar (US Regulatory) | Form 8-K - Current report |
2/15/2024 | 15:27 | Edgar (US Regulatory) | Form 8-K - Current report |
1/05/2024 | 07:34 | Edgar (US Regulatory) | Form 8-K - Current report |
11/21/2023 | 12:11 | Edgar (US Regulatory) | Form 8-K - Current report |
11/20/2023 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/14/2023 | 15:44 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
9/29/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
8/17/2023 | 15:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/14/2023 | 15:45 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTGL Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.01 | 0.015 | 0.01 | 0.013003 | 167 | 0.005 | 50.00% |
1 Month | 0.01 | 0.015 | 0.01 | 0.0100197 | 10,154 | 0.005 | 50.00% |
3 Months | 0.0072 | 0.0153 | 0.0072 | 0.0101433 | 3,811 | 0.0078 | 108.33% |
6 Months | 0.0187 | 0.022 | 0.005 | 0.0150079 | 5,943 | -0.0037 | -19.79% |
1 Year | 0.0399 | 0.0419 | 0.005 | 0.0243117 | 7,887 | -0.0249 | -62.41% |
3 Years | 0.03035 | 0.085 | 0.005 | 0.033119 | 16,403 | -0.01535 | -50.58% |
5 Years | 0.18 | 0.287 | 0.005 | 0.0541188 | 17,291 | -0.165 | -91.67% |
Citrine Global (PK) Description
Citrine Global Corp. is a plant-based wellness & pharma solutions company with its business activity comprised of developing wellness and pharma solutions, focused on science backed plant-based products to improve quality of life and complementary solutions for balancing side effects caused by using medicines, treatments, or an unbalanced lifestyle. Our headquarters and senior management are based in Israel where we operate via our 100%-owned-subsidiary, Citrine Global Israel & 60%-owned-subsidiary, Cannovation Center. Our presence in Israel and our contacts with leading universities, companies, and governmental support powers us to access the latest technologies. We developed more than 100 wellness products & nutritional supplements under the Green Side by Side and GreenFeels brands and plan to market them worldwide in compliance with local regulations, focusing on the U.S. market, through building a global network of local teams and partnerships with distributors, retail and pharmacy chains, and M&As with distribution companies. We are building the Green Vision Center, a first-of-its-kind production and innovation center, providing in a single location everything required for production, innovation, and release-to-market of plant-based wellness & pharma products. Our mission is to leverage the power of plant-based solutions from nature and bring to market, on a global scale, innovative plant-based wellness & pharma solutions to improve people's quality of life. |